Sfoglia per RIVISTA
JOURNAL OF CLINICAL ONCOLOGY : OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY
Collezione AOU San Luigi di Orbassano

  

Items : 22

Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2024 Oct 20;42(30):3593-3605. doi: 10.1200/JCO.24.01001. Epub 2024 Jun 10.

2024
AOU San Luigi di Orbassano

Leighl NB; Akamatsu H; Lim SM; Cheng Y; Minchom AR; Marmarelis ME; Sanborn RE; Chih-Hsin Yang J; Liu B; John T; Massutí B; Spira AI; Lee SH; Wang J; Li J; Liu C; Novello S; Kondo M; Tamiya M; Korbenfeld E; Moskovitz M; Han JY; Alexander M; Joshi R; Felip E; Voon PJ; Danchaivijitr P; Hsu PC; Silva Melo Cruz FJ; et alii...

SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2024 Jan 20;42(3):324-335. doi: 10.1200/JCO.23.01363. Epub 2023 Nov 17.

2024
AOU San Luigi di Orbassano

Rudin CM; Liu SV; Soo RA; Lu S; Hong MH; Lee JS; Bryl M; Dumoulin DW; Rittmeyer A; Chiu CH; Ozyilkan O; Johnson M; Navarro A; Novello S; Ozawa Y; Tam SH; Patil NS; Wen X; Huang M; Hoang T; Meng R; Reck M; Rudin CM; Liu SV; Soo RA; Lu S; Hong MH; Lee JS; Bryl M; et alii...

Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Nov 1;41(31):4852-4863. doi: 10.1200/JCO.23.01361. Epub 2023 Sep 11.

2023
AOU San Luigi di Orbassano

Goto K; Goto Y; Kubo T; Ninomiya K; Kim SW; Planchard D; Ahn MJ; Smit EF; de Langen AJ; Pérol M; Pons-Tostivint E; Novello S; Hayashi H; Shimizu J; Kim DW; Kuo CH; Yang JC; Pereira K; Cheng FC; Taguchi A; Cheng Y; Feng W; Tsuchihashi Z; Jänne PA;

Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16). in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Jul 10;41(20):3608-3615. doi: 10.1200/JCO.22.01726. Epub 2023 Feb 8.

2023
AOU San Luigi di Orbassano

Gillessen S; Procopio G; Hayoz S; Kremer E; Schwitter M; Caffo O; Lorente D; Pedrazzini A; Roubaud G; Nenan S; Omlin A; Buttigliero C; Delgado Mingorance JI; González-Del-Alba A; Delgado MT; Nole F; Turco F; Pereira Mestre R; Ribi K; Cathomas R;

Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 Nov 10;39(32):3633-3644. doi: 10.1200/JCO.20.03318. Epub 2021 Aug 26.

2021
AOU San Luigi di Orbassano

Ramalingam SS; Novello S; Guclu SZ; Bentsion D; Zvirbule Z; Szilasi M; Bernabe R; Syrigos K; Byers LA; Clingan P; Bar J; Vokes EE; Govindan R; Dunbar M; Ansell P; He L; Huang X; Sehgal V; Glasgow J; Bach BA; Mazieres J;

Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 Aug 10;39(23):2574-2585. doi: 10.1200/JCO.20.02574. Epub 2021 Jun 2.

2021
AOU San Luigi di Orbassano

Ferrara R; Facchinetti F; Del Re M; Bertolaccini L; Cinquini M; Passiglia F; Franchina T; Larici AR; Malapelle U; Menis J; Passaro A; Pilotto S; Ramella S; Rossi G; Trisolini R; Novello S;

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 May 10;38(14):1505-1517. doi: 10.1200/JCO.19.03136. Epub 2020 Mar 9.

2020
AOU San Luigi di Orbassano

Gadgeel S; Rodríguez-Abreu D; Speranza G; Esteban E; Felip E; Dómine M; Hui R; Hochmair MJ; Clingan P; Powell SF; Cheng SY; Bischoff HG; Peled N; Grossi F; Jennens RR; Reck M; Garon EB; Novello S; Rubio-Viqueira B; Boyer M; Kurata T; Gray JE; Yang J; Bas T; Pietanza MC; Garassino MC;

Long-Term Outcomes and Retreatment Among Patients With Previously Treated, Programmed Death-Ligand 1?Positive, Advanced Non?Small-Cell Lung Cancer in the KEYNOTE-010 Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 May 10;38(14):1580-1590. doi: 10.1200/JCO.19.02446. Epub 2020 Feb 20.

2020
AOU San Luigi di Orbassano

Herbst RS; Garon EB; Kim DW; Cho BC; Perez-Gracia JL; Han JY; Arvis CD; Majem M; Forster MD; Monnet I; Novello S; Szalai Z; Gubens MA; Su WC; Ceresoli GL; Samkari A; Jensen EH; Lubiniecki GM; Baas P;

Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung Cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 Jan 20;38(3):271-280. doi: 10.1200/JCO.19.01348. Epub 2019 Nov 21.

2020
AOU San Luigi di Orbassano

Mazieres J; Kowalski D; Luft A; Vicente D; Tafreshi A; Gümü? M; Laktionov K; Hermes B; Cicin I; Rodríguez-Cid J; Wilson J; Kato T; Ramlau R; Novello S; Reddy S; Kopp HG; Piperdi B; Li X; Burke T; Paz-Ares L; Mazieres J; Kowalski D; Luft A; Vicente D; Tafreshi A; Gümü? M; Laktionov K; Hermes B; Cicin I; et alii...

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2018 Feb 10;36(5):454-462. doi: 10.1200/JCO.2017.75.2543. Epub 2018 Jan 23.

2018
AO Cuneo
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Rambaldi A; Gianni AM; Pavoni C; Chauvie S; Bergesio F; Prosperini G; Chiaravalloti A; Gregianin M; Ficola U; Fallanca F; Biggi A; Avigdor A; Billio A; Miglino M; Viero P; Ferreri AJM; Gini G; Zanotti R; Parvis G; Schiavotto C; Cimminiello M; Corradini P; Gavarotti P; Battistini R; Gottardi D; Rapezzi D; Bolis S; Trentin L; La Nasa G; et alii...

Immediate or Delayed Nephrectomy in Patients With Metastatic Renal Cancer Who Are Receiving Targeted Agents: Is the Analysis at Risk for Guarantee-Time Bias? in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2017 Apr 10;35(11):1264. doi: 10.1200/JCO.2016.69.3580. Epub 2017 Feb 6.

2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Vignani F; Tucci M; Buttigliero C;

Subgroup Analysis: Refining a Positive Result or Trying to Rescue a Negative One? in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2015 Dec 20;33(36):4310. doi: 10.1200/JCO.2015.62.6747. Epub 2015 Sep 21.

2015
AOU San Luigi di Orbassano

Di Maio M; Perrone F;

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2014 Mar 1;32(7):634-40. doi: 10.1200/JCO.2013.52.0023. Epub 2014 Jan 21.

2014
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ria R; Offidani M; Gaidano G; Passera R; Nozzoli C; Guglielmelli T; Mina R; Morabito F; Marasca R; Omedé P; Bringhen S; Larocca A; Rossi D; Di Raimondo F; Magarotto V; Patriarca F; Levi A; Benevolo G; Vincelli ID; Grasso M; Franceschini L; Gottardi D; Zambello R; Montefusco V; Falcone AP; Palumbo A; Petrucci MT; Musto P; Boccadoro M; et alii...

Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2014 Dec 1;32(34):3883-91. doi: 10.1200/JCO.2014.55.2836. Epub 2014 Oct 27.

2014
AOU San Luigi di Orbassano

Berruti A; Amoroso V; Gallo F; Bertaglia V; Simoncini E; Pedersini R; Ferrari L; Bottini A; Bruzzi P; Sormani MP;

Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced follicular lymphoma: a phase III randomized study by the Fondazione Italiana Linfomi. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2013 Sep 20;31(27):3351-9. doi: 10.1200/JCO.2012.44.8290. Epub 2013 Aug 19.

2013
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ladetto M; Boccomini C; Baldini L; De Angelis F; Tucci A; Botto B; Chiappella A; Vitolo U; Chiarenza A; Pinto A; De Renzo A; Zaja F; Castellino C; Bari A; Alvarez De Celis I; Evangelista A; Parvis G; Gamba E; Lobetti-Bodoni C; Ciccone G; Rossi G;

Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2011 Mar 1;29(7):814-24. doi: 10.1200/JCO.2010.28.9777. Epub 2010 Dec 28.

2011
AOU San Luigi di Orbassano

Tarella C; Passera R; Magni M; Benedetti F; Rossi A; Gueli A; Patti C; Parvis G; Ciceri F; Gallamini A; Cortelazzo S; Zoli V; Corradini P; Carobbio A; Mulé A; Bosa M; Barbui A; Di Nicola M; Sorio M; Caracciolo D; Gianni AM; Rambaldi A;

Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2010 Mar 20;28(9):1534-9. doi: 10.1200/JCO.2009.25.9275. Epub 2010 Feb 22.

2010
AOU San Luigi di Orbassano

Righi L; Papotti MG; Ceppi P; Billè A; Bacillo E; Molinaro L; Ruffini E; Scagliotti GV; Selvaggi G;

Phase III study of carboplatin and paclitaxel alone or with sorafenib in advanced non-small-cell lung cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2010 Apr 10;28(11):1835-42. doi: 10.1200/JCO.2009.26.1321. Epub 2010 Mar 8.

2010
AOU San Luigi di Orbassano

Scagliotti G; Novello S; von Pawel J; Reck M; Pereira JR; Thomas M; Abrão Miziara JE; Balint B; De Marinis F; Keller A; Arén O; Csollak M; Albert I; Barrios CH; Grossi F; Krzakowski M; Cupit L; Cihon F; Dimatteo S; Hanna N;

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2008 Jul 20;26(21):3543-51. doi: 10.1200/JCO.2007.15.0375. Epub 2008 May 27.

2008
AOU San Luigi di Orbassano

Scagliotti GV; Parikh P; von Pawel J; Biesma B; Vansteenkiste J; Manegold C; Serwatowski P; Gatzemeier U; Digumarti R; Zukin M; Lee JS; Mellemgaard A; Park K; Patil S; Rolski J; Goksel T; de Marinis F; Simms L; Sugarman KP; Gandara D;

Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: a retrospective case-control study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2006 Oct 20;24(30):4818-24. doi: 10.1200/JCO.2006.06.1952.

2006
AOU San Luigi di Orbassano

Papotti M; Kalebic T; Volante M; Chiusa L; Bacillo E; Cappia S; Lausi P; Novello S; Borasio P; Scagliotti GV;

Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2003 Apr 15;21(8):1556-61. doi: 10.1200/JCO.2003.06.122.

2003
AOU San Luigi di Orbassano

Scagliotti GV; Shin DM; Kindler HL; Vasconcelles MJ; Keppler U; Manegold C; Burris H; Gatzemeier U; Blatter J; Symanowski JT; Rusthoven JJ;

Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial design. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2002 Oct 15;20(20):4150-9. doi: 10.1200/JCO.2002.08.012.

2002
AOU San Luigi di Orbassano

Berruti A; Bitossi R; Gorzegno G; Bottini A; Alquati P; De Matteis A; Nuzzo F; Giardina G; Danese S; De Lena M; Lorusso V; Farris A; Sarobba MG; DeFabiani E; Bonazzi G; Castiglione F; Bumma C; Moro G; Bruzzi P; Dogliotti L;